arrow
返回

BASIC AND TRANSLATIONAL-LIVER

delete2013-06-01
delete329
delete
OA
AI
R
Robert E. Lanford *
B
Bernadette Guerra
D
Deborah Chavez
L
Luis D. Giavedoni
V
Vida Hodara
K
Kathleen M. Brasky
A
Abigail Fosdick
C
Christian Frey
J
Jim Zheng
G
Grushenka H.I. Wolfgang
R
Randall L. Halcomb
D
Daniel B. Tumas
DOI:10.1053/j.gastro.2013.02.003delete
delete原文链接
delete分享
delete收藏
摘要

摘要

En 中文
BACKGROUND & AIMS: Direct-acting antiviral agents suppress hepatitis B virus (HBV) load, but they require life-long use. Stimulation of the innate immune system could increase its ability to control the virus and have long-lasting effects after a finite regimen. We investigated the effects of immune activation with GS-9620-a potent and selective orally active small molecule agonist of Tolllike receptor 7-in chimpanzees with chronic HBV infection. METHODS: GS-9620 was administered to chimpanzees every other day (3 times each week) for 4 weeks at 1 mg/kg and, after a 1-week rest, for 4 weeks at 2 mg/kg. We measured viral load in plasma and liver samples, the pharmacokinetics of GS-9620, and the following pharmacodynamics parameters: interferon-stimulated gene expression, cytokine and chemokine levels, lymphocyte and natural killer cell activation, and viral antigen expression. Clinical pathology parameters were monitored to determine the safety and tolerability of GS-9620. RESULTS: Short-term oral administration of GS-9620 provided long-term suppression of serum and liver HBV DNA. The mean maximum reduction of viral DNA was 2.2 logs, which occurred within 1 week of the end of GS-9620 administration; reductions of > 1 log persisted for months. Serum levels of HBV surface antigen and HBV e antigen, and numbers of HBV antigen-positive hepatocytes, were reduced as hepatocyte apoptosis increased. GS-9620 administration induced production of interferon-alpha and other cytokines and chemokines, and activated interferon-stimulated genes, natural killer cells, and lymphocyte subsets. CONCLUSIONS: The small molecule GS-9620 activates Toll-like receptor 7 signaling in immune cells of chimpanzees to induce clearance of HBV-infected cells. This reagent might be developed for treatment of patients with chronic HBV infection.
Keyword:
Innate Immunity
Interferon-alpha
Antiviral
Pathogen Recognition
TLR-7

期刊

Gastroenterology 封面图
Gastroenterology
IF:
25.1
论文数:
4.0W
被引数:
9.0W

机构

G
Gilead Sciences
学者数:
162
论文数: 23
被引数: 0
T
texas biomedical research institute
学者数:
252
论文数: 20
被引数: 0
引用论文

引用论文

Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA
err2011-06-20
err111
errOAAI
errLanford, Robert E.; Feng, Zongdi; Chavez, Deborah; Guerra, Bernadette; Brasky, Kathleen M.; Zhou, Yan; Yamane, Daisuke; Perelson, Alan S.; Walker, Christopher M.; Lemon, Stanley M.
err分享
err收藏
Detection of Clonally Expanded Hepatocytes in Chimpanzees with Chronic Hepatitis B Virus Infection
err2009-09-01
err60
errOAAI
errMason, William S.; Low, Huey-Chi; Xu, Chunxiao; Aldrich, Carol E.; Scougall, Catherine A.; Grosse, Arend; Clouston, Andrew; Chavez, Deborah; Litwin, Samuel; Peri, Suraj; Jilbert, Allison R.; Lanford, Robert E.
err分享
err收藏
Genomic response to interferon-α in chimpanzees:: Implications of rapid downregulation for hepatitis C kinetics
err2006-05-01
err110
errOAAI
errLanford, RE; Guerra, B; Lee, H; Chavez, D; Brasky, KM; Bigger, CB
err分享
err收藏
Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway小型抗病毒化合物通过TLR7 MyD88-dependent信号通路激活免疫细胞
err2002-01-22
err2.4K
PREAI
errHemmi, H; Kaisho, T; Takeuchi, O; Sato, S; Sanjo, H; Hoshino, K; Horiuchi, T; Tomizawa, H; Takeda, K; Akira, S
err分享
err收藏
Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a
err2009-06-01
err262
errOAAI
errMarcellin, Patrick; Bonino, Ferruccio; Lau, George K. K.; Farci, Patrizia; Yurdaydin, Cihan; Piratvisuth, Teerha; Jin, Rui; Gurel, Selim; Lu, Zhi-Meng; Wu, Jian; Popescu, Matei; Hadziyannis, Stephanos
err分享
err收藏
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy在阿德福韦酯治疗期间慢性乙型肝炎的自然史和下降的cccDNA的持久性
err2004-06-01
err830
errOAAI
errWerle-Lapostolle, B; Bowden, S; Locarnini, S; Wursthorn, K; Petersen, J; Lau, G; Trepo, C; Marcellin, P; Goodman, Z; Delaney, WE; Xiong, S; Brosgart, CL; Chen, SS; Gibbs, CS; Zoulim, F
err分享
err收藏
学者 查看更多内容